Resources

Find out about how opposition parties are positioning themselves in an increasingly fragmented political landscape, and what it might mean for our sector now and in the long term.

It’s TechBio week and we’re celebrating the UK’s leading role in AI and life sciences with significant investment and interest from global players and our own flagship TechBio UK conference and 2025 report launch. 

BIA and Japan Bioindustry Association signed an MOU, agreeing to work together to connect the two countries’ life sciences and biotech ecosystems to accelerate medical innovation and the commercialisation of engineering biology.

Good to see support for BIA agendas in government messaging as we continue to push for pension fund reform, attracting the best global talent, UK manufacturing resilience and addressing the challenges of scaling.

Ellie Avni, Senior Director in Employment Tax and Reward at FTI Consulting, explores how the new PISCES platform could reshape EMI and CSOP share option plans – creating fresh opportunities for flexibility and tax-efficient value realisation.

The BIA moves into a new era this week, amidst news from the US on tariffs for UK pharma, UK political party conferences underway and a change in leadership at GSK. It’s full steam ahead for BIA towards a busy Autumn, ensuring that the life science sector stays at the top of the government’s priority list and that our members are represented and connected.

New Moderna Innovation and Technology Centre opened as government further boosts life sciences sector with £50 million fund.

In the third part of our series on Industrial Strategy, Lewis Miles and Maddie Cass provide a deep dive into the Digital and Technologies Sector Plan, analysing how these policies aim to foster growth in the UK's life sciences and engineering biology sectors. We also look forward to strengthening relations and gaining key insight from our US sister organisation with BIO's upcoming UK visit.

In the third instalment of our updates on new Government policy, Lewis Miles and Maddie Cass from BIA’s Policy and Public Affairs team take a deep dive into the Industrial Strategy and the Digital and Technologies Sector Plan, breaking down the implications for engineering biology and the wider life sciences sector.  

In the second instalment of our blog series on new government policy, Lewis Miles and Linda Bedenik examine the UK's Trade and National Security strategies and what they mean for biotech.

In a shifting global landscape, we break down how the UK's new Trade and National Security strategies aim to future-proof our biotech sector.

In this blog, Martin Turner, Director of Policy and External Affairs at BIA, reflects on the long-anticipated Life Sciences Sector Plan and what it means for scaling UK biotech. This is the first in a series of blogs that will be released in the coming weeks.

In my final summer update as BIA CEO, I reflect on 12 amazing years and look ahead to my new role as Executive Chair of the Office for Life Sciences. This week we’ve also published our latest finance report, and we’re hiring - so if you’re looking for your next challenge, now’s the time to join Team BIA.

In this blog, Dr Jonathan Tobin, Partner, Brandon Capital, explores how the UK pension industry can unlock greater economic and societal value by following Australia's example.

After 13 years at the helm of our Association, Steve Bates has tendered his resignation as CEO of the BIA. His last day at the BIA will be Friday, 26 September 2025. We all wish him well in his new role and know he will continue to champion our sector at home and abroad. 

A response from Discovery Park’s CEO, Mayer Schreiber, in light of the Government’s Life Science Sector Plan.

In this article, Kate Barclay, Skills Strategy Consultant at BIA, outlines new changes to UK immigration law and how they will impact the life sciences sector. Prepared in collaboration with legal experts at Eversheds-Sutherland LLP.